Skip to main content
. 2017 Jun 19;8(37):62693–62702. doi: 10.18632/oncotarget.18570

Figure 2.

Figure 2

(A) Cardiac output (CO) in liraglutide group (n = 26) and control group (n = 26) from baseline to day 7. (B) Cardiac index (CI) in liraglutide group (n = 26) and control group (n = 26) from baseline to day 7.